Fundraising Fox

Pathalys

Research Triangle Park, US · Founded 2021 · 18 employees on LinkedIn · 7 known investors

Pathalys Pharma is a private biopharmaceutical company developing treatments for kidney disease, including upacicalcet, which is in late-stage development. The company is working toward an NDA submission and pre-commercialization efforts.

Investors · 7

Also in the syndicate · 2

J.P. Morgan Life Sciences Private CapitalTCGXlead

Funding

SEC filings, press & company announcements
  • Undisclosed amountseries BAug 2024

    TCGX (lead), J.P. Morgan Life Sciences Private Capital

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Pathalys do?
Pathalys Pharma is a private biopharmaceutical company developing treatments for kidney disease, including upacicalcet, which is in late-stage development. The company is working toward an NDA submission and pre-commercialization efforts.
Who are Pathalys's investors?
Pathalys's investors include Catalys Pacific, OrbiMed, Samsara BioCapital, Abingworth, KB Investment.
Where is Pathalys headquartered?
Pathalys is headquartered in Research Triangle Park, US.